Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Synthetic Biologics Inc (SYN)
NYSE MKT:SYN
Synthetic Biologics (SYN) Financial Statements
0 Followers
Synthetic Biologics Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -4.99M | $ -4.25M | $ -5.26M | $ -3.27M | $ -3.20M |
| EBITDA | $ -4.97M | $ -4.23M | $ -5.25M | $ -3.26M | $ -3.17M |
| Net Income Common Stockholders | $ -4.97M | $ -4.27M | $ -5.26M | $ -3.27M | $ -3.19M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.00M | $ 6.23M | $ 52.27M | $ 56.69M | $ 67.33M |
| Total Assets | $ 82.33M | $ 89.00M | $ 70.36M | $ 75.12M | $ 77.25M |
| Total Debt | $ 232.00K | $ 361.00K | $ 445.00K | $ 1.59M | $ 1.60M |
| Net Debt | $ -5.77M | $ -5.87M | $ -51.82M | $ -55.10M | $ -65.73M |
| Total Liabilities | $ 20.66M | $ 20.97M | $ 4.96M | $ 4.56M | $ 3.52M |
| Stockholders Equity | $ 6.68M | $ 8.03M | $ 61.67M | $ 65.41M | $ 68.03M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.37M | $ -4.90M | $ -4.81M | $ -2.16M | $ -2.60M |
| Operating Cash Flow | $ -4.36M | $ -4.90M | $ -4.81M | $ -2.16M | $ -2.60M |
| Investing Cash Flow | $ -14.00K | $ -4.28M | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ -1.38M | $ 0.00 | $ 0.00 | $ 0.00 |
Synthetic Biologics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.